Home › Products › Oncology › GEM RTU 1.4gm Injection
GEM RTU 1.4gm Injection
Salt Composition: GEMCITABINE
- Manufacturer: ADLEY FORMULATIONS
- Pack Size: 1 VIAL(s) OF 36.84ML
- Dosage Form: INJECTION
- Strength: 1400MG
- Prescription Required
- Storage: Keep gem RTU 1.4gm injection out of sight and reach of children. This medicine does not require any special storage conditions. Do not refrigerate or freeze.
₹3375.00₹13125.00
Inclusive of all taxes
Product Introduction
Gem RTU 1.4gm injection is a chemotherapy medication containing the active ingredient gemcitabine. It is indicated for the treatment of bladder, breast, ovarian, pancreatic, and non-small cell lung cancers. Cancer is a disorder characterised by uncontrolled and abnormal cell multiplication. Inform your doctor if you have heart disease, liver disorders, kidney disorders, have recently undergone radiotherapy, or have been vaccinated before commencing this medicine. Gem RTU 1.4gm injection is not recommended for adolescents and children under 18 years of age. Your doctor will assess your blood cell counts and kidney and liver function at each administration of this medicine. Use effective contraception during treatment and for at least six months after the final dose. This medicine may impair fertility in male patients. Men taking this medicine should not father a child during treatment and for 6 months following treatment. Inform your physician if you follow a salt-controlled diet, as this medicine contains sodium. Contact your doctor immediately if you experience shortness of breath, wheezing, changes in colour or volume of urine, bleeding, or upper abdominal pain while taking Gem RTU 1.4gm injection.
Uses
Bladder cancer, in combination with cisplatin Ovarian cancer, in combination with carboplatin Breast cancer, in combination with paclitaxel Pancreatic cancer Non-small cell lung cancer (NSCLC), alone or in combination with cisplatin
How it works
Gem RTU 1.4gm injection blocks the ability of cancer cells to process DNA replication, which is essential for the cells to divide and grow. This can prevent or stop the growth of cancer cells.
How to Use
Gem RTU 1.4gm injection is administered as an intravenous infusion into the vein. If this injection is recommended for you, it will be given by a healthcare professional. Do not self-administer. Your physician will choose the dosage and administration frequency based on the medical condition because it differs for each person.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them. Serious Pulmonary toxicity (shortness of breath, wheezing, cough) Hemolytic-uremic syndrome (Changes in the volume or colour of urine, increased bruising, or bleeding) Pain or tenderness in the upper abdomen Allergic reactions, rashes, fever, swelling or sores in the mouth Common Nausea, vomiting Low blood cell count Loss of appetite Hair loss Swelling of ankles, feet, and fingers Insomnia Constipation, diarrhea Headache Running nose, chills Muscle pain, back pain Sweating hair loss liver problems blood in urine abnormal urine test Oedema (swelling of ankles, fingers, feet, face)
Expert Tips
It is not recommended to take gem RTU 1.4gm injection if you are allergic to Gemcitabine or any of its ingredients. During this treatment, your doctor may periodically monitor your complete blood counts, blood sugar, electrolytes, liver panel, and kidney parameters to prevent serious complications. This injection may impair fertility in male patients. Men taking this injection are advised not to father a child during the treatment and for 6 months after the treatment. Consult your doctor before starting this injection, and it is advised to get suggestions about fertility concerns from your doctor. It is advised for both men and women to follow proper contraceptive methods during and after the 6 months of the last dose.
References
- Sun Pharmaceutical Industries, Electronic medicines compendium (EMC), [Revised on May 2022] [Accessed on 20 Mar 2023], https://www.medicines.org.uk/emc/files/pil.7298.pdf
- Hospira, Inc, US Food and Drug Administration, [Revised on June 2019 [Accessed on 20 Mar 2023], https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020509s077lbl.pdf
- Goodman & Gilmanâs, The Pharmacological Basis of Therapeutics, Cytotoxic agents, 12th edition, 2011, 1700
- KD Tripathi, Essentials of Medical Pharmacology, Anticancer drugs, 7th edition, 2013, 870.
Safety Advice
Pregnancy: unsafe Gem RTU 1.4gm injection can cause harm to your unborn baby. Tell your doctor if you are pregnant or planning to get pregnant before taking the drug.
Lungs: Consult your doctor Gem RTU 1.4gm injection is used cautiously in a patient with a lung disorder. Inform your doctor if you have any lung disease.
Breastfeeding: unsafe You must not breastfeed while being treated with gem RTU 1.4gm injection. Inform your doctor if you are breastfeeding before taking this treatment.
Disclaimer
The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.